Nakularch Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-07-2024
- Paid Up Capital ₹ 0.10 M
as on 27-07-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 27-07-2024
- Revenue 0.51%
(FY 2023)
- Profit 52.87%
(FY 2023)
- Ebitda 12.56%
(FY 2023)
- Net Worth 45.07%
(FY 2023)
- Total Assets -2.29%
(FY 2023)
About Nakularch Meditech
The Corporate was formerly known as Nakularch Meditech (Opc) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Kuldeep Singh, Deepika, Abrar Ahmad, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999UP2017PTC093303
- Company No.
093303
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nakularch Meditech Private Limited offer?
Nakularch Meditech Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Antibacterial Drugs, Digestive System Drugs & Medicines, Anti Ulcer Drugs, Anti Infective Agent, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Common Disease Medicines, Injectable Products.
Who are the key members and board of directors at Nakularch Meditech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kuldeep Singh  | Director | 19-May-2017 | Current |
| Deepika | Director | 12-Jun-2021 | Current |
| Abrar Ahmad | Director | 15-Feb-2024 | Current |
| Amarjeet Verma | Director | 15-Feb-2024 | Current |
Financial Performance of Nakularch Meditech.
Nakularch Meditech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.51% increase. The company also saw a substantial improvement in profitability, with a 52.87% increase in profit. The company's net worth Soared by an impressive increase of 45.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nakularch Meditech?
In 2023, Nakularch Meditech had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nakularch Designers & Engineers Private LimitedActive 5 years 5 monthsKuldeep Singh is a mutual person
- Nakularch Hospitals Private LimitedActive 3 years 4 months
Kuldeep Singh and Deepika are mutual person
- Lyf Medicare Sales And Services Private LimitedActive 3 years 5 months
Abrar Ahmad is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 25 Feb 2021 | ₹3.50 M | Open |
How Many Employees Work at Nakularch Meditech?
Unlock and access historical data on people associated with Nakularch Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nakularch Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nakularch Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
